Background Liquid biopsy (LB) is a rapidly evolving diagnostic tool for precision oncology
that has recently found its way into routine practice as an adjunct to tissue biopsy (TB). The …

Tissue-based biopsy is the present main tool to explore the molecular landscape of cancer,
but it also has many limits to be frequently executed, being too invasive with the risk of side …

Pancreatic cancer is a lethal condition with a rising incidence and often presents at an
advanced stage, contributing to abysmal five-year survival rates. Unspecific symptoms and …

Imaging and image-guided procedures play an imperative role in the screening, diagnosis,
and surveillance of cancer. Although emerging imaging techniques now enable more …

Pancreatic cancer is one of the most fatal malignancies, as approximately 80% of patients
are at advanced stages by the time of diagnosis. The main reason for the poor overall …

Pancreatic cancer is a deadly disease with limited therapeutic options. Several strategies
are being investigated to improve disease management, including the early diagnosis of …

Pancreatic cancer is one of the main causes of cancer-related deaths worldwide. It is
asymptomatic at an early stage, and most diagnosis occurs when the disease is already at a …

Liquid biopsy may assist in the management of cancer patients, which can be particularly
applicable in pancreatic ductal adenocarcinoma (PDAC). In this study, we investigated the …

Pancreatic cancer is an aggressive, solid tumor, with a grave prognosis. Despite surgical
treatment in patients with pancreatic cancer, the rate of recurrence is high. In addition …

Purpose Recent advances in molecular diagnostic technologies allow for the evaluation of
solid tumor malignancies through noninvasive blood sampling, including circulating tumor …